Tumor-associated neutrophils repress NK cell cytotoxicity through the PD-1/PD-L1 axis, and their depletion combined with PD-L1 blockade was significantly better in reducing tumor burden than either monotherapy [46]. Here, CD274 is linked to neoplasm.